Biosensors International Groupltdis A Prominent Developer And Manufacturer Of Medical Devicesfocusing On Interventional Cardiology And Critical Carefounded In 1989 And Based In Singaporethe Company Has A Strong Global Presenceincluding A European Headquarters In Morgesswitzerlandthe Company Specializes In Interventional Cardiology Devicesparticularly Known For Its Innovative Cardiovascular Stent Technologiesincluding The Patented Biolimus A9A C Drug And Biodegradable Polymer Stentsadditionallybiosensors Offers Critical Care Catheter Systems Used In Heart Surgery And Intensive Carethey Also Engage In Cardiac Diagnostics And Generate Revenue Through Licensing Agreementswith An Annual Revenue Of $92 8 Million And A Workforce Of Approximately 469 Employeesbiosensors Is Dedicated To Advancing Medical Technology And Improving Patient Outcomes While Supporting Medical Education And Environmental Responsibility
